Ashvattha Therapeutics (“Ashvattha”), a clinical-stage company advancing a new class of nanomedicine therapeutics that traverse tissue barriers to selectively target and reprogram activated cells in ...

DeepSeek has shown that China can, in part, sidestep US restrictions on advanced chips by leveraging algorithmic innovations.